Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May-Jun;32(3):296-305.
doi: 10.5144/0256-4947.2012.296.

The current lymphoma classification: new concepts and practical applications triumphs and woes

Nasir Bakshi  1 , Irfan Maghfoor
Affiliations
Review

The current lymphoma classification: new concepts and practical applications triumphs and woes

Nasir Bakshi et al. Ann Saudi Med. 2012 May-Jun.

Abstract

The World Health Organization (WHO) classification of lymphomas updated in 2008 represents an international consensus for diagnosis of lymphoid neoplasms based on the recognition of distinct disease entities by applying a constellation of clinical and laboratory features. The 2008 classification has refined and clarified the definitions of well-recognized diseases, identified new entities and variants, and incorporated emerging concepts in the understanding of lymphoid neoplasms. Rather than being a theoretical scheme this classification has used data from published literature. Recent knowledge of molecular pathways has led to identification and development of new diagnostic tools, like gene expression profiling, which could complement existing technologies. However, some questions remain unresolved, such as the extent to which specific genetic or molecular alterations define certain tumors. In general, practical considerations and economics preclude a heavily molecular and genetic approach. The significance of early or precursor lesions and the identification of certain lymphoid neoplasms is less clear at present, but understanding is evolving. The borderline categories having overlapping features with large B-cell lymphomas, as well as some of the provisional entities, are subject to debate and lack consensus in management. Lastly, the sheer number of entities may be overwhelming, especially, for the diagnosing pathologist, who do not see enough of these on a regular basis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Germinal center B cells (GCB) vs activated B cell (ABC) diffuse large B-cell lymphoma (Non-GCB) by immunohistochemistry based on Hans et al.
Figure 2
Figure 2
Biologic interfaces or gray zones classical Hodgkin lymphoma and other B-cell lymphomas. MED LBCL: Mediastinal large B-cell lymphoma; DLBCL: Diffuse large B-cell lymphoma; T/HRLBCL: T-cell/histiocyte rich large B-cell lymphoma
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
    1. Jaffe ES, Harris NL, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
    1. National Cancer Registry. Kingdom of Saudi Arabia: Ministry of Health; 2006. Cancer Incidence Report Saudi Arabia.
    1. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937–1947. - PubMed
    1. Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood. 2005;105(5):1851–1861. - PubMed